Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1278 | 2747 | 32.5 | 64% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
405 | 3 | BACTERIORHODOPSIN//G PROTEIN COUPLED RECEPTOR//G PROTEIN | 29641 |
705 | 2 | G PROTEIN COUPLED RECEPTOR//GPCR//RHODOPSIN | 12950 |
1278 | 1 | MUSCARINIC RECEPTOR SUBTYPES//MUSCARINIC RECEPTORS//PIRENZEPINE | 2747 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MUSCARINIC RECEPTOR SUBTYPES | authKW | 343112 | 3% | 40% | 77 |
2 | MUSCARINIC RECEPTORS | authKW | 268576 | 9% | 10% | 250 |
3 | PIRENZEPINE | authKW | 162571 | 2% | 26% | 57 |
4 | AF DX 116 | authKW | 108409 | 1% | 49% | 20 |
5 | MCN A 343 | authKW | 90004 | 1% | 45% | 18 |
6 | TRIPITRAMINE | authKW | 69244 | 0% | 69% | 9 |
7 | MUSCARINIC ACETYLCHOLINE RECEPTOR | authKW | 62647 | 2% | 11% | 52 |
8 | M 2 SELECTIVITY | authKW | 55570 | 0% | 100% | 5 |
9 | MED PHARM CHIM BIOL NUTR | address | 55570 | 0% | 100% | 5 |
10 | METHOCTRAMINE | authKW | 55355 | 1% | 29% | 17 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 25883 | 56% | 0% | 1544 |
2 | Chemistry, Medicinal | 3073 | 11% | 0% | 289 |
3 | Neurosciences | 1618 | 16% | 0% | 446 |
4 | Biochemistry & Molecular Biology | 649 | 17% | 0% | 465 |
5 | Medicine, Research & Experimental | 533 | 6% | 0% | 174 |
6 | Biophysics | 115 | 3% | 0% | 96 |
7 | Chemistry, Organic | 84 | 4% | 0% | 117 |
8 | Physiology | 76 | 3% | 0% | 79 |
9 | Cell Biology | 65 | 5% | 0% | 129 |
10 | Toxicology | 9 | 1% | 0% | 38 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MED PHARM CHIM BIOL NUTR | 55570 | 0% | 100% | 5 |
2 | MED BIOCHEM NUTRBLDG GECP 611 | 22228 | 0% | 100% | 2 |
3 | MED PSYCHIAT MOLEC NEUROPHARMACOL SECT | 22228 | 0% | 100% | 2 |
4 | SURG GUT MOTIL | 22228 | 0% | 100% | 2 |
5 | VICTORIAN PHARM PHARMACOL | 22228 | 0% | 100% | 2 |
6 | MED BIOCHEM NUTR BLVD WATERLOO 115 | 16668 | 0% | 50% | 3 |
7 | DIPARTIMENTO FARMACOL PRECLIN CLIN | 13943 | 1% | 8% | 15 |
8 | PHARMAKOL NAT WISSEN | 13885 | 0% | 25% | 5 |
9 | NEURONAL NETWORK | 12688 | 0% | 14% | 8 |
10 | BIOZENTRUM NIEDERURSEL | 11827 | 0% | 15% | 7 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 20737 | 7% | 1% | 199 |
2 | EUROPEAN JOURNAL OF PHARMACOLOGY | 18798 | 8% | 1% | 219 |
3 | BRITISH JOURNAL OF PHARMACOLOGY | 15293 | 6% | 1% | 157 |
4 | NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 14100 | 3% | 1% | 88 |
5 | EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 12668 | 1% | 3% | 35 |
6 | MOLECULAR PHARMACOLOGY | 11958 | 4% | 1% | 103 |
7 | JOURNAL OF AUTONOMIC PHARMACOLOGY | 11864 | 1% | 4% | 30 |
8 | TRENDS IN PHARMACOLOGICAL SCIENCES | 10546 | 2% | 2% | 57 |
9 | LIFE SCIENCES | 10182 | 5% | 1% | 137 |
10 | JOURNAL OF MEDICINAL CHEMISTRY | 5037 | 4% | 0% | 100 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MUSCARINIC RECEPTOR SUBTYPES | 343112 | 3% | 40% | 77 | Search MUSCARINIC+RECEPTOR+SUBTYPES | Search MUSCARINIC+RECEPTOR+SUBTYPES |
2 | MUSCARINIC RECEPTORS | 268576 | 9% | 10% | 250 | Search MUSCARINIC+RECEPTORS | Search MUSCARINIC+RECEPTORS |
3 | PIRENZEPINE | 162571 | 2% | 26% | 57 | Search PIRENZEPINE | Search PIRENZEPINE |
4 | AF DX 116 | 108409 | 1% | 49% | 20 | Search AF+DX+116 | Search AF+DX+116 |
5 | MCN A 343 | 90004 | 1% | 45% | 18 | Search MCN+A+343 | Search MCN+A+343 |
6 | TRIPITRAMINE | 69244 | 0% | 69% | 9 | Search TRIPITRAMINE | Search TRIPITRAMINE |
7 | MUSCARINIC ACETYLCHOLINE RECEPTOR | 62647 | 2% | 11% | 52 | Search MUSCARINIC+ACETYLCHOLINE+RECEPTOR | Search MUSCARINIC+ACETYLCHOLINE+RECEPTOR |
8 | M 2 SELECTIVITY | 55570 | 0% | 100% | 5 | Search M+2+SELECTIVITY | Search M+2+SELECTIVITY |
9 | METHOCTRAMINE | 55355 | 1% | 29% | 17 | Search METHOCTRAMINE | Search METHOCTRAMINE |
10 | 4 DAMP | 48482 | 0% | 36% | 12 | Search 4+DAMP | Search 4+DAMP |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | EGLEN, RM , HEGDE, SS , WATSON, N , (1996) MUSCARINIC RECEPTOR SUBTYPES AND SMOOTH MUSCLE FUNCTION.PHARMACOLOGICAL REVIEWS. VOL. 48. ISSUE 4. P. 531 -565 | 200 | 53% | 397 |
2 | MITCHELSON, FJ , (2012) THE PHARMACOLOGY OF MCN-A-343.PHARMACOLOGY & THERAPEUTICS. VOL. 135. ISSUE 2. P. 216 -245 | 149 | 50% | 4 |
3 | MITCHELSON, F , (1988) MUSCARINIC RECEPTOR DIFFERENTIATION.PHARMACOLOGY & THERAPEUTICS. VOL. 37. ISSUE 3. P. 357-423 | 205 | 63% | 175 |
4 | CAULFIELD, MP , (1993) MUSCARINIC RECEPTORS - CHARACTERIZATION, COUPLING AND FUNCTION.PHARMACOLOGY & THERAPEUTICS. VOL. 58. ISSUE 3. P. 319-379 | 160 | 39% | 924 |
5 | GRIMM, U , MOSER, U , MUTSCHLER, E , LAMBRECHT, G , (1994) MUSCARINIC RECEPTORS - FOCUS ON PRESYNAPTIC MECHANISMS AND RECENTLY DEVELOPED NOVEL AGONISTS AND ANTAGONISTS.PHARMAZIE. VOL. 49. ISSUE 10. P. 711-726 | 121 | 71% | 35 |
6 | CAULFIELD, MP , BIRDSALL, NJM , (1998) INTERNATIONAL UNION OF PHARMACOLOGY. XVII. CLASSIFICATION OF MUSCARINIC ACETYLCHOLINE RECEPTORS.PHARMACOLOGICAL REVIEWS. VOL. 50. ISSUE 2. P. 279 -290 | 69 | 54% | 925 |
7 | HULME, EC , BIRDSALL, NJM , BUCKLEY, NJ , (1990) MUSCARINIC RECEPTOR SUBTYPES.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 30. ISSUE . P. 633-673 | 65 | 58% | 1067 |
8 | MEI, L , ROESKE, WR , YAMAMURA, HI , (1989) MOLECULAR PHARMACOLOGY OF MUSCARINIC RECEPTOR HETEROGENEITY.LIFE SCIENCES. VOL. 45. ISSUE 20. P. 1831-1851 | 82 | 85% | 124 |
9 | NATHANSON, NM , (1987) MOLECULAR-PROPERTIES OF THE MUSCARINIC ACETYLCHOLINE-RECEPTOR.ANNUAL REVIEW OF NEUROSCIENCE. VOL. 10. ISSUE . P. 195-236 | 99 | 55% | 464 |
10 | WANG, ZG , SHI, H , WANG, HZ , (2004) FUNCTIONAL M-3 MUSCARINIC ACETYLCHOLINE RECEPTORS IN MAMMALIAN HEARTS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 142. ISSUE 3. P. 395-408 | 61 | 55% | 62 |
Classes with closest relation at Level 1 |